Literature DB >> 11024413

Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: II. Quality of life outcomes submacular surgery trials pilot study report number 2.

.   

Abstract

PURPOSE: To summarize findings from health-related quality-of-life interviews with patients who had recurrent subfoveal choroidal neovascularization secondary to age-related macular degeneration and participated in a randomized pilot trial (focal confluent laser photocoagulation versus submacular surgery) that may assist in planning future assessments of health-related quality of life in patients with age-related macular degeneration. PATIENTS AND METHODS: Of 70 patients enrolled in the pilot trial, 54 were interviewed before random assignment to treatment and provided the data analyzed for this report. Patients were scheduled for follow-up interviews at 6, 12, and 24 months after enrollment. The 36-Item Short-Form Health Survey was used in all cases and was administered by an interviewer. The summary scales, Physical Component Summary and Mental Component Summary, were the focus of this analysis.
RESULTS: Median Physical Component Summary and Mental Component Summary score at baseline were 47 and 53, respectively. Distributions of scores at baseline and throughout the 2-year follow-up period were similar in the two treatment arms and consistent with those of a sample of the general US population of similar age. Distributions of both Physical Component Summary scores and Mental Component Summary scores for individual patient subgroups at baseline suggested sensitivity to some measures of baseline vision. During 2 years of follow-up interviews, median changes in Physical Component Summary scores were decreases of six points in the laser arm and three points in the surgery arm; in both treatment arms, median change in Mental Component Summary scores was an increase of 2 points. Two-year changes in visual acuity had no discernible effect on Physical Component Summary scores or Mental Component Summary scores; baseline scores were the strongest predictors of 2-year changes in Physical Component Summary and Mental Component Summary scores.
CONCLUSIONS: Overall, summary scores from the 36-Item Short-Form Health Survey and changes in scores over 2 years in this pilot trial were consistent with the ophthalmic outcome measures (reported elsewhere) that showed no important differences between the treatment arms. These health-related quality-of-life findings provided assurance that the similarity of ophthalmic outcomes in the two treatment arms did not mask changes potentially important to patients that were not captured as part of the clinical outcome data.

Entities:  

Mesh:

Year:  2000        PMID: 11024413     DOI: 10.1016/s0002-9394(00)00730-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6.

Authors:  Eric B Bass; Marsha J Marsh; Carol M Mangione; Neil M Bressler; Ashley L Childs; Li Ming Dong; Barbara S Hawkins; Harris A Jaffee; Päivi Miskala
Journal:  Arch Ophthalmol       Date:  2004-12

Review 2.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10.

Authors:  Barbara S Hawkins; Päivi H Miskala; Eric B Bass; Neil M Bressler; Ashley L Childs; Carol M Mangione; Marta J Marsh
Journal:  Arch Ophthalmol       Date:  2004-11

4.  Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2.

Authors:  M R Stevenson; P M Hart; U Chakravarthy; G Mackenzie; A C Bird; S L Owens; I H Chisholm; V Hall; R F Houston; D W McCulloch; N Plowman
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.

Authors:  Päivi H Miskala; Barbara S Hawkins; Carol M Mangione; Eric B Bass; Neil M Bressler; Li Ming Dong; Marta J Marsh; Lee D McCaffrey
Journal:  Arch Ophthalmol       Date:  2003-04

Review 6.  Quality of life in age-related macular degeneration: a review of the literature.

Authors:  Jan Mitchell; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-12-21       Impact factor: 3.186

7.  Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akira Hirata; Ken Hayashi; Kazuhisa Murata; Kei-Ichiro Nakamura
Journal:  Am J Ophthalmol Case Rep       Date:  2017-12-19

8.  Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?

Authors:  Hugo Quiroz-Mercado; Andrés Lisker-Cervantes; Luis Arroyo; Naresh Mandava; Frank S Siringo; Miguel Paciuc-Beja; Roberto Gonzalez-Salinas
Journal:  Am J Ophthalmol Case Rep       Date:  2019-05-10

9.  What explains health in persons with visual impairment?

Authors:  Juliane Leissner; Michaela Coenen; Stephan Froehlich; Danny Loyola; Alarcos Cieza
Journal:  Health Qual Life Outcomes       Date:  2014-05-03       Impact factor: 3.186

10.  Ab-interno surgical technique for the implantation of a wireless subretinal prosthesis in mini-pigs.

Authors:  Kwang-Eon Choi; Vu Thi Que Anh; Hee Won Seo; Namju Kim; Sohee Kim; Seong-Woo Kim
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.